Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|July 14, 2007
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategiesM Rusnati, M Presta
International Journal of Clinical & Laboratory Research|January 1, 1996
Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularizationM Rusnati, M Presta
Journal of Cellular Physiology|January 1, 1993
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptorsM Rusnati, C Urbinati, M Presta
The Journal of Biological Chemistry|October 12, 2000
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycansM Tyagi, M Rusnati, M Presta, et al.
Journal of Cellular Physiology|December 1, 1989
Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cellsM Presta, J A Maier, M Rusnati, et al.
Experimental Cell Research|February 1, 1990
Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cellsJ A Maier, M Rusnati, G Ragnotti, et al.
Journal of Cellular Physiology|July 1, 1989
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active formM Presta, J A Maier, M Rusnati, et al.
Biochemical and Biophysical Research Communications|September 30, 1988
Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive formM Presta, M Rusnati, J A Maier, et al.
Molecular Biology of the Cell|December 17, 1997
alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cellsM Rusnati, E Tanghetti, P Dell'Era, et al.
Gynecologic Oncology|January 1, 1993
Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometriumM Rusnati, G Casarotti, S Pecorelli, et al.
Pageof 6